Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Evolocumab (Repatha) in Cardiac Transplant Patients With Coronary Allograft Vasculopathy

NCT03944577 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT03944577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03944577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Evolocumab (Repatha) in Cardiac Transplant Patients With Coronary Allograft Vasculopathy
Lead sponsor
University of Nebraska
Phase
Phase 2
Overall status
Completed
Start date
July 15, 2019
Completion date
March 28, 2023
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart transplant